Athira Pharma Inc.

13F holders, Q3 2025 (September 30)
2holders −49
0new positions
19sold out
$0.57avg. 13F price*

At the end of Q3 2025, 2 institutions reported holding Athira Pharma Inc. in their 13F filings, down 49 from Q2 2025. 0 opened new positions and 19 sold out. The largest holders were Osaic Holdings, Inc. ($380) and Global Retirement Partners, LLC ($215).

Company
Athira Pharma Inc.
CUSIP
04746L104
Latest filing quarter
Q3 2025

History

Number of 13F holders

020406080 Q1 2024: 75Q1 2024Q2 2024: 65Q2 2024Q3 2024: 58Q3 2024Q4 2024: 56Q4 2024Q1 2025: 54Q1 2025Q2 2025: 51Q2 2025Q3 2025: 2Q3 2025

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions0$0
Exits19$205K

All 13F filers, Q2 2025 → Q3 2025: 741,743 shares sold, net −741,743 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 2 holders

Osaic Holdings, Inc. 0.00% Reduce -98.3% 1,000 $380
Global Retirement Partners, LLC 0.00% Reduce -90.0% 52 $215

"% of holder's portfolio" is ATHIRA PHARMA INC's weight in each manager's 13F, not the share of Athira Pharma Inc. the manager owns.